Usha Vyas

568 total citations
8 papers, 413 citations indexed

About

Usha Vyas is a scholar working on Molecular Biology, Surgery and Nephrology. According to data from OpenAlex, Usha Vyas has authored 8 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Surgery and 2 papers in Nephrology. Recurrent topics in Usha Vyas's work include Gut microbiota and health (4 papers), Gastrointestinal motility and disorders (2 papers) and Diet and metabolism studies (2 papers). Usha Vyas is often cited by papers focused on Gut microbiota and health (4 papers), Gastrointestinal motility and disorders (2 papers) and Diet and metabolism studies (2 papers). Usha Vyas collaborates with scholars based in United States and Mexico. Usha Vyas's co-authors include Natarajan Ranganathan, Pari Ranganathan, Subodh J. Saggi, Eli A. Friedman, Alan Weinberg, Aditya Sudhalkar, Tejas Desai, Mary C. Mallappallil, Allen J. Norin and Edilia Tapia and has published in prestigious journals such as PLoS ONE, Journal of the American Society of Nephrology and BioMed Research International.

In The Last Decade

Usha Vyas

8 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Usha Vyas United States	5	224	123	100	88	58	8	413
Emmanuel Anteyi Nigeria	8	132 0.6×	91 0.7×	135 1.4×	23 0.3×	24 0.4×	11	391
P Wunderlich Germany	13	148 0.7×	130 1.1×	57 0.6×	92 1.0×	38 0.7×	43	530
J. A. Guzmán Argentina	12	179 0.8×	113 0.9×	21 0.2×	51 0.6×	31 0.5×	23	555
Masanori Kakuta Japan	8	368 1.6×	21 0.2×	183 1.8×	50 0.6×	44 0.8×	15	482
Jianmin Qiao China	5	336 1.5×	164 1.3×	78 0.8×	95 1.1×	47 0.8×	6	479
Pari Ranganathan United States	6	334 1.5×	248 2.0×	188 1.9×	58 0.7×	65 1.1×	9	540
Jui‐Fen Chen Taiwan	11	186 0.8×	53 0.4×	89 0.9×	95 1.1×	47 0.8×	17	370
Małgorzata Moszak Poland	10	232 1.0×	21 0.2×	180 1.8×	43 0.5×	134 2.3×	21	590
Carla Juliana Ribeiro Dolenga Brazil	11	290 1.3×	288 2.3×	253 2.5×	33 0.4×	92 1.6×	15	642

Countries citing papers authored by Usha Vyas

Since Specialization

Citations

This map shows the geographic impact of Usha Vyas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Usha Vyas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Usha Vyas more than expected).

Fields of papers citing papers by Usha Vyas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Usha Vyas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Usha Vyas. The network helps show where Usha Vyas may publish in the future.

Co-authorship network of co-authors of Usha Vyas

This figure shows the co-authorship network connecting the top 25 collaborators of Usha Vyas. A scholar is included among the top collaborators of Usha Vyas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Usha Vyas. Usha Vyas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Ranganathan, Natarajan, et al.. (2020). A Double-Blind, Randomized, Placebo-Controlled with an Open-Label Rollover Extension Phase 2/3 Clinical Trial to Evaluate Safety and Efficacy of US-APR2020 in Subjects with CKD Stage IV. Journal of the American Society of Nephrology. 31(10S). 801–801. 1 indexed citations

2.

García‐Arroyo, Fernando E., Edilia Tapia, Virgilia Soto, et al.. (2018). Probiotic supplements prevented oxonic acid-induced hyperuricemia and renal damage. PLoS ONE. 13(8). e0202901–e0202901. 67 indexed citations

3.

Ranganathan, Noopur, et al.. (2018). Improvements in Glomerular Filtration Rate (GFR) in Chronic Kidney Disease (CKD) Patients Using a Commercial Patented and Proprietary ProbioticPrebiotic Formulation* -3rd Biennial Survey. 4(1). 4 indexed citations

4.

Ranganathan, Natarajan, et al.. (2017). Quality of Life in Chronic Kidney Disease Patients Using a Synbiotic Dietary Supplement: a Survey. 2(1). 1 indexed citations

5.

Saggi, Subodh J., Kelly Mercier, Jessica Gooding, et al.. (2017). Metabolic profiling of a chronic kidney disease cohort reveals metabolic phenotype more likely to benefit from a probiotic.. PubMed. 12(1). 43–54. 10 indexed citations

6.

Ranganathan, Natarajan, Usha Vyas, Pari Ranganathan, et al.. (2014). Randomized Controlled Trial of Strain-Specific Probiotic Formulation (Renadyl) in Dialysis Patients. BioMed Research International. 2014. 1–9. 122 indexed citations

7.

Desai, Tejas, et al.. (2013). Methanol Poisoning. JAMA Ophthalmology. 131(3). 358–358. 47 indexed citations

8.

Vyas, Usha & Natarajan Ranganathan. (2012). Probiotics, Prebiotics, and Synbiotics: Gut and Beyond. Gastroenterology Research and Practice. 2012. 1–16. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact